MiniMed® Duo™ Enhances Simplicity and Comfort of Sensor Augmented Insulin Pump Therapy

Two-in-One Breakthrough Enhances Simplicity and Comfort in Continuous Glucose Monitoring 

Medtronic today announced the European launch of MiniMed® Duo™, the world’s first two-in-one breakthrough that combines a glucose sensor and insulin infusion set into one on-body device, simplifying integrated insulin pump therapy and continuous glucose monitoring (CGM). MiniMed Duo, which is used with the MiniMed® Veo™ system, makes it easier for more people with diabetes to benefit from CGM. 

Insulin pumps provide precise insulin delivery and lifestyle flexibility for people with diabetes by delivering small amounts of insulin around-the-clock. Insulin pumps integrated with CGM are clinically proven to provide better glucose control than multiple daily injections  or pump therapy alone . Better glucose control reduces the risk of diabetes complications such as eye disease, kidney disease and nerve damage.  Insulin pumps with built-in CGM provide people with diabetes with real-time glucose values and customizable alerts that give warning before glucose levels go too high or too low, prompting the person with diabetes to take action. The MiniMed® Veo™ is the only integrated system with an automatic insulin shut-off mechanism if glucose levels fall too low, providing protection against hypoglycemia (low blood glucose). Traditional finger stick tests alone often miss up to 78% of potentially dangerous highs and lows , resulting in a higher risk for diabetes complications. 

“CGM provides people with diabetes with real-time information about their glucose levels that is invaluable in helping them optimize their diabetes management.  However, in the past, many people have been reluctant to use a system that requires them to wear two separate devices on their bodies. By integrating a glucose sensor and infusion set into one device, MiniMed Duo will make it easier and more comfortable for these patients to adopt and experience the benefits of CGM technology,” said Dr. Francine Kaufman, Chief Medical Officer and Vice President of Global Clinical Affairs for Medtronic Diabetes. 

Benefits of the MiniMed Duo include:

• Enhanced simplicity:

o Both the glucose sensor and cannula (the tiny tube that goes into the body to deliver the insulin) are inserted with one easy-to-use insertion device. 

o People with diabetes only have to remember to change one device every 3-days.

o There’s no need to manage two different sites on the body while bathing, exercising or being active.

• Greater comfort:

o A smaller footprint on the body (compared to a separate CGM sensor and infusion set) means less skin covered by adhesive tape. 

o A single-button insertion and automatic needle retraction (so patients don’t have to see the needle) were specifically designed for greater comfort.

Nyhetsinfo

www red DiabetologNytt